PERSISTENCE TO DENOSUMAB IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AT INCREASED FRACTURE RISK TREATED IN ROUTINE CLINICAL PRACTICE IN BULGARIA

被引：0
|
作者：
Monov, S. [1 ]
Nestorova, R. [2 ]
Velkova, M. [3 ]
Temelkova, N. [4 ]
Jeleva, S. [5 ]
Petkova, R. [6 ]
Petranova, T. [1 ]
机构：
[1] Med Univ, Clin Rheumatol, Sofia, Bulgaria
[2] ASIMP RC St Irina, Sofia, Bulgaria
[3] ASIMP Rheumatol, Russe, Bulgaria
[4] Univ Hosp Alexandrovska, Sofia, Bulgaria
[5] Med Ctr Orfey, St Zagora, Bulgaria
[6] Amgen Bulgaria, Sofia, Bulgaria
来源：
OSTEOPOROSIS INTERNATIONAL | 2020年 / 31卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P856
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [21] Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab
    Keaveny, Tony M.
    McClung, Michael R.
    Genant, Harry K.
    Zanchetta, Jose R.
    Kendler, David
    Brown, Jacques P.
    Goemaere, Stefan
    Recknor, Chris
    Brandi, Maria L.
    Eastell, Richard
    Kopperdahl, David L.
    Engelke, Klaus
    Fuerst, Thomas
    Radcliffe, Hoi-Shen
    Libanati, Cesar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (01) : 158 - 165
  • [22] Postmenopausal women treated for DTC are at risk of osteoporosis
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 (10): : 534 - 534
  • [23] FREEDOM TRIAL: DENOSUMAB IS NOT ASSOCIATED WITH FRACTURE HEALING COMPLICATIONS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Adami, Silvano
    Palacios, Santiago
    Pavelka, Karel
    Resch, Heinrich
    Roux, Christian
    Uebelhart, Daniel
    Ho, Pei-Ran
    Wang, Andrea
    Siris, Ethel
    Libanati, Cesar
    Adachi, Jonathan
    Boonen, Steven
    Cummings, Steven
    de Gregorio, Luiz
    Gilchrist, Nigel
    Lyritis, George
    Moeller, Gerd
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 243 - 244
  • [24] Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice
    Mihail Boyanov
    Alexander Shinkov
    Emi Psachoulia
    Michele Intorcia
    Reneta Petkova
    Drugs in R&D, 2017, 17 : 125 - 132
  • [25] Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice
    Boyanov, Mihail
    Shinkov, Alexander
    Psachoulia, Emi
    Intorcia, Michele
    Petkova, Reneta
    DRUGS IN R&D, 2017, 17 (01) : 125 - 132
  • [26] Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis
    McClung, Michael R.
    Boonen, Steven
    Torring, Ove
    Roux, Christian
    Rizzoli, Rene
    Bone, Henry G.
    Benhamou, Claude-Laurent
    Lems, Willem F.
    Minisola, Salvatore
    Halse, Johan
    Hoeck, Hans C.
    Eastell, Richard
    Wang, Andrea
    Siddhanti, Suresh
    Cummings, Steven R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (01) : 211 - 218
  • [27] Denosumab for the Treatment of Postmenopausal Women at Increased Risk of Osteoporotic Fractures
    Bogado, Cesar E.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 395 - 402
  • [28] Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review
    Vestergaard, Peter
    Thomsen, Susanna Vid Streym
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2009, 1 : 97 - 103
  • [29] The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
    Zhu, Yilin
    Huang, Zhonglian
    Wang, Yan
    Xu, Weicai
    Chen, Hongjiang
    Xu, Jiankun
    Luo, Shaowei
    Zhang, Yuantao
    Zhao, Di
    Hu, Jun
    JOURNAL OF ORTHOPAEDIC TRANSLATION, 2020, 22 : 7 - 13
  • [30] Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
    N. B. Watts
    C. Roux
    J. F. Modlin
    J. P. Brown
    A. Daniels
    S. Jackson
    S. Smith
    D. J. Zack
    L. Zhou
    A. Grauer
    S. Ferrari
    Osteoporosis International, 2012, 23 : 327 - 337
12345